05/15/2024
3:39 PM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:10 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:26 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:15 PM | Apogee Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:16 PM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:18 PM | Apogee Therapeutics (Filer)
| Form ARS | |
|
04/01/2024
4:42 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
4:44 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:30 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:01 AM | Apogee Therapeutics (Filer)
| Form 424B4 | |
03/07/2024
11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
03/07/2024
5:27 PM | Apogee Therapeutics (Filer)
| Form S-1MEF | |
03/05/2024
7:15 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:11 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:15 AM | Apogee Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:35 AM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Apogee Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/31/2024
3:31 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest II L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:41 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:45 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2023
7:38 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/28/2023
7:00 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:19 AM | Apogee Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/07/2023
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:05 PM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G | |
07/21/2023
3:31 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D | |
07/17/2023
7:00 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest II L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
7:00 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
7:01 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:59 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 3/A | |
07/17/2023
4:03 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 3/A | |
07/17/2023
4:04 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 3/A | |
07/17/2023
4:05 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 3/A | |
07/17/2023
4:06 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 3/A | |
Look Who Fired the World’s Richest Man (Ad) This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S.
And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman. Get the full story here. |
07/17/2023
3:08 PM | Apogee Therapeutics (Filer)
| Form 424B4 | |
07/13/2023
11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
07/13/2023
5:39 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:39 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:40 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:40 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:41 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/13/2023
5:42 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/12/2023
12:13 PM | Apogee Therapeutics (Filer)
| Form CERT | |
07/10/2023
3:00 PM | Apogee Therapeutics (Filer)
| Form 8-A12B | |
07/10/2023
5:01 AM | Apogee Therapeutics (Filer)
| Form S-1/A | |
07/03/2023
3:44 PM | Apogee Therapeutics (Filer)
| Form S-1/A | |
06/22/2023
3:19 PM | Apogee Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
